article · Trends in Natural Products Research
Gongronema latifolium is a climbing shrub traditionally used in Nigerian ethnomedicine for hypertension, diabetes, malaria, digestive disorders, and as a nutrient-rich vegetable high in proteins, vitamins, and minerals. This study aimed to evaluate the effects of methanol leaf extract of G. latifolium (GLE) on blood pressure, electrocardiographic (ECG) parameters, oxidative stress, organ function, lipid profiles, histoarchitecture, and endothelial nitric oxide synthase (eNOS) expression in L-NAME-induced hypertensive rats. G. latifolium leaf was washed, dried and extracted with 70% methanol. Thirty-five male Wistar rats (150-200 g) were divided into seven groups (n=5): control (distilled water), L-NAME (40 mg/kg), GLE alone (100 mg/kg), L-NAME + GLE (50, 100, 200 mg/kg), and L-NAME + captopril (40 mg/kg). Oral treatments lasted 28 days. Non-invasive tail-cuff blood pressure, ECG, serum biomarkers (lipids, liver/kidney enzymes, electrolytes, oxidative stress markers), immunohistochemistry for eNOS, was assessed. Data were analyzed via one-way ANOVA with Tukey’s post-hoc (P < 0.05). L-NAME significantly elevated systolic/diastolic/mean arterial blood pressures, heart rate, prolonged ECG intervals (P, PR, QRS, QTc), increased MDA, liver/kidney markers, lipids (T-CHOL, TG, LDL, VLDL, CRI), and chloride, It reduced HDL, antioxidants (GSH, SOD, CAT, GST, nitrite), and eNOS expression in the aorta and heart, GLE dose-dependently reduced blood pressures, normalized most ECG parameters (except QTc prolongation at 200 mg/kg), boosted antioxidants/nitrite, normalized organ/lipid/electrolyte markers (LDL reductions 9.6-18.1%, CRI 10.6-17.6%), and upregulated aortic eNOS.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.61594/tnpr.v7i2.2026.164
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.